雷贝拉唑钠在幽门螺杆菌阳性十二指肠溃疡患者中的应用效果
2018-05-23石晋金峰何春生
石晋 金峰 何春生

【摘要】 目的:探讨以雷贝拉唑钠为中心的四联方案治疗幽门螺杆菌阳性十二指肠溃疡(DU)的临床效果。方法:选取2015年1月-2016年2月笔者所在医院消化内科收治的100例Hp阳性DU患者为研究对象。根据随机数字表法将其分为观察组(53例)和对照组(47例)。对照组患者给予传统四联疗法,即“奥美拉唑+阿莫西林+克拉霉素+枸橼酸铋钾”的四联方案;观察组质子泵抑制剂(PPI)替换为雷贝拉唑钠。疗程为14 d。对比两组患者的治疗有效率、Hp根除情况及不良反应发生情况。结果:观察组患者治疗总有效率明显高于对照组,差异有统计学意义(字2=7.231,P<0.05)。观察组患者Hp根除率为96.23%(51/53),明显高于对照组的80.85%(38/47),差异有统计学意义(字2=5.527,P<0.05)。两组均无因严重不良反应而中断治疗患者。结论:以雷贝拉唑钠为中心的四联方案治疗Hp阳性DU的效果显著,可提高Hp根除率,不良反应小,安全性高。
【关键词】 十二指肠溃疡; 幽门螺杆菌; 雷贝拉唑钠; 质子泵抑制剂
doi:10.14033/j.cnki.cfmr.2018.9.010 文献标识码 B 文章编号 1674-6805(2018)09-0021-03
Application of Rabeprazole Sodium in Patients with Helicobacter Pylori Positive Duodenal Ulcer/SHI Jin,JIN Feng,HE Chunsheng.//Chinese and Foreign Medical Research,2018,16(9):21-23
【Abstract】 Objective:To investigate the clinical effect with Rabeprazole as the center in the treatment of Helicobacter pylori(Hp) positive duodenal ulcer(DU).Method:From January 2015 to February 2016,100 patients with Hp positive DU were enrolled in this study and were divided into observation group(53 cases) and control group(47 cases) according to the random number table method.In the control group,patients were treated with traditional quadruple therapy,namely “Omeprazole,Amoxicillin,Clarithromycin and Bismuth Potassium Citrate”;the Proton Pump Inhibitor(PPI) in the observation group was replaced with Rabeprazole Sodium.The course of treatment was 14 days.Compared the two groups of patients with the efficiency of treatment,Hp eradication and adverse reactions occurred.Result:The total effective rate of the treatment group was significantly higher than that of the control group(字2=7.231,P<0.05).The eradication rate of Hp in the observation group was 96.23%(51/53),which was significantly higher than 80.85%(38/47) in the control group,the difference was statistically significant(字2=5.527,P<0.05).None of the two groups discontinued treatment due to serious adverse events.Conclusion:The treatment of Hp-positive DU with Rabeprazole Sodium as the center is significant,and the eradication rate of Hp is high,the adverse reaction is small and the safety is high.
【Key words】 Duodenal ulcer; Helicobacter pylori; Rabeprazole Sodium; Proton Pump Inhibitor
First-authors address:Peoples Liberation Army No.476 Hospital,Fuzhou 350002,China
十二指腸溃疡(duodenal ulcer,DU)是我国人群中常见病、多发病之一。胃液分泌增多,黏膜变弱,造成胃或十二指肠的内壁溃烂或受伤,就是胃或十二指肠溃疡,多由不规律的饮食习惯或过度紧张等造成。临床上DU多于胃溃疡,两者之比约为3∶1[1]。DU发病率最高的年龄段为30~39岁。其治疗的重点在于规范用药和足疗程用药,否则可能会因溃疡反复发作而引起严重后果[2]。胃溃疡和DU同属消化性溃疡,二者内科治疗基本相同。在专科医师或临床药师指导下,应用抑酸药、胃黏膜保护药,以及H2受体拮抗药和质子泵抑制药进行正规抗溃疡治疗。对幽门螺杆菌(HP)阳性的消化性溃疡患者,进行抗Hp治疗可大大减少溃疡病复发。但胃溃疡和DU在发病机制上有一定差异,所以治疗策略上略有不同。……
